1,934
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients

ORCID Icon & ORCID Icon
Pages 805-814 | Received 31 May 2022, Accepted 26 Oct 2022, Published online: 21 Nov 2022

References

  • Albietz JM, Lenton LM. 2006. Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease. Cornea. 25(9):1012–1019.
  • Andersson J, Vogt JK, Dalgaard MD, Pedersen O, Holmgaard K, Heegaard S. 2021. Ocular surface microbiota in patients with aqueous tear-deficient dry eye. Ocul Surf. 19:210–217.
  • Aoki T, Kitazawa K, Deguchi H, Sotozono C. 2021. Current evidence for Corynebacterium on the ocular surface. Microorganisms. 9(2):254.
  • Aragona P, Baudouin C, Benitez Del Castillo JM, Messmer E, Barabino S, Merayo-Lloves J, Brignole-Baudouin F, Inferrera L, Rolando M, Mencucci R, et al. 2021. The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders. Surv Ophthalmol. 66(6):907–925.
  • Barbosa FL, Xiao Y, Bian F, Coursey T, Ko BY, Clevers H, De Paiva CS, Plugfelder SC. 2017. Goblet cells contribute to ocular surface immune tolerance-implications for dry eye disease. Int J Mol Sci. 18(5):18050978.
  • Berry M, Harris A, Lumb R, Powell K. 2002. Commensal ocular bacteria degrade mucins. Br J Ophthalmol. 86(12):1412–1416.
  • Blais DR, Vascotto SG, Griffith M, Altosaar I. 2005. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Invest Ophthalmol Vis Sci. 46(11):4235–4244.
  • Bomar L, Brugger SD, Yost BH, Davies SS, Lemon KP. 2016. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio. 7(1):e01725.
  • Burkovski A. 2018. The role of corynomycolic acids in Corynebacterium-host interaction. Antonie Van Leeuwenhoek. 111(5):717–725.
  • Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, Dana R. 2009. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 182(3):1247–1252.
  • Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. 2018. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 138:271–281.
  • Clayton JA. 2018. Dry Eye. N Engl J Med. 378(23):2212–2223.
  • Contreras-Ruiz L, Masli S. 2015. Immunomodulatory cross-talk between conjunctival goblet cells and dendritic cells. PLoS One. 10(3):e0120284.
  • Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo C-K, Liu Z, Nelson JD, Nichols JJ, Tsubota K, et al. 2017. TFOS DEWS II Definition and Classification Report. Ocul Surf. 15(3):276–283.
  • De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KF, Niederkorn JY, et al. 2009. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2(3):243–253.
  • De Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, et al. 2016. Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci Rep. 6:23561.
  • Delbeke H, Casteels I, Joossens M. 2022. The effect of topical anesthetics on 16S ribosomal ribonucleic acid amplicon sequencing results in ocular surface microbiome research. Transl Vis Sci Technol. 11(3):2.
  • Deng Y, Wen X, Hu X, Zou Y, Zhao C, Chen X, Miao L, Li X, Deng X, Bible PW, et al. 2020. Geographic difference shaped human ocular surface metagenome of young Han Chinese from Beijing, Wenzhou, and Guangzhou cities. Invest Ophthalmol Vis Sci. 61(2):47.
  • Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, Revanna KV, Gao X, Antonopoulos DA, Slepak VZ, et al. 2011. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 52(8):5408–5413.
  • Dong X, Wang Y, Wang W, Lin P, Huang Y. 2019. Composition and diversity of bacterial community on the ocular surface of patients with meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 60(14):4774–4783.
  • Garbutcheon-Singh KB, Carnt N, Pattamatta U, Samarawickrama C, White A, Calder V. 2019. A review of the cytokine IL-17 in ocular surface and corneal disease. Curr Eye Res. 44(1):1–10.
  • Goldin A, Beckman JA, Schmidt AM, Creager MA. 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 114(6):597–605.
  • Graham JE, Moore JE, Jiru X, Moore JE, Goodall EA, Dooley JSG, Hayes VEA, Dartt DA, Downes CS, Moore TCB, et al. 2007. Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci. 48(12):5616–5623.
  • Hoshi S, Todokoro D, Sasaki T. 2020. Corynebacterium species of the conjunctiva and nose: dominant species and species-related differences of antibiotic susceptibility profiles. Cornea. 39(11):1401–1406.
  • Kaiserman I, Kaiserman N, Nakar S, Vinker S. 2005. Dry eye in diabetic patients. Am J Ophthalmol. 139(3):498–503.
  • Kim HC, Cho YJ, Ahn CW, Park KS, Kim JC, Nam JS, Im YS, Lee JE, Lee SC, Lee HK, et al. 2009. Nerve growth factor and expression of its receptors in patients with diabetic neuropathy. Diabet Med. 26(12):1228–1234.
  • Kittipibul T, Puangsricharern V, Chatsuwan T. 2020. Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects. Sci Rep. 10(1):4353.
  • Kugadas A, Christiansen SH, Sankaranarayanan S, Surana NK, Gauguet S, Kunz R, Fichorova R, Vorup-Jensen T, Gadjeva M. 2016. Impact of microbiota on resistance to ocular Pseudomonas aeruginosa-induced keratitis. PLoS Pathog. 12(9):e1005855.
  • Kunze WA, Mao Y-K, Wang B, Huizinga JD, Ma X, Forsythe P, Bienenstock J. 2009. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med. 13(8b):2261–2270.
  • Lam SM, Tong L, Yong SS, Li B, Chaurasia SS, Shui G, Wenk MR. 2011. Meibum lipid composition in Asians with dry eye disease. PLoS One. 6(10):e24339.
  • Lanza NL, Valenzuela F, Perez VL, Galor A. 2016. The matrix metalloproteinase 9 point-of-care test in dry eye. Ocul Surf. 14(2):189–195.
  • Lee HS, Hattori T, Park EY, Stevenson W, Chauhan SK, Dana R. 2012. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest Ophthalmol Vis Sci. 53(9):5632–5640.
  • Leppin K, Behrendt A-K, Reichard M, Stachs O, Guthoff RF, Baltrusch S, Eule JC, Vollmar B. 2014. Diabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the cornea. Invest Ophthalmol Vis Sci. 55(6):3603–3615.
  • Li S, Yi G, Peng H, Li Z, Chen S, Zhong H, Chen Y, Wang Z, Deng Q, Fu M, et al. 2019. How ocular surface microbiota debuts in type 2 diabetes mellitus. Front Cell Infect Microbiol. 9:202.
  • Li Z, Gong Y, Chen S, Li S, Zhang Y, Zhong H, Wang Z, Chen Y, Deng Q, Jiang Y, et al. 2019. Comparative portrayal of ocular surface microbe with and without dry eye. J Microbiol. 57(11):1025–1032.
  • Liang Q, Li J, Zou Y, Hu X, Deng X, Zou B, Liu Y, Wei L, Liang L, Wen X, et al. 2021. Metagenomic analysis reveals the heterogeneity of conjunctival microbiota dysbiosis in dry eye disease. Front Cell Dev Biol. 9:731867.
  • Liu R, Gao C, Chen H, Li Y, Jin Y, Qi H. 2017. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PLoS One. 12(4):e0173301.
  • Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. 2008. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol. 8:10.
  • Mao Y-K, Kasper DL, Wang B, Forsythe P, Bienenstock J, Kunze WA. 2013. Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun. 4:1465.
  • McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, Knoop KA, Newberry RD, Miller MJ. 2012. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature. 483(7389):345–349.
  • McKee LS, La Rosa SL, Westereng B, Eijsink VG, Pope PB, Larsbrink J. 2021. Polysaccharide degradation by the Bacteroidetes: mechanisms and nomenclature. Environ Microbiol Rep. 13(5):559–581.
  • Na K-S, Hwang K-Y, Lee H-S, Chung S-H, Mok JW, Joo C-K. 2015. Wakayama symposium: interface between innate and adaptive immunity in dry eye disease. BMC Ophthalmol. 15(S1):159.
  • Ozkan J, Willcox M, Wemheuer B, Wilcsek G, Coroneo M, Thomas T. 2019. Biogeography of the human ocular microbiota. Ocul Surf. 17(1):111–118.
  • Ozkan J, Willcox MD. 2019. The ocular microbiome: molecular characterisation of a unique and low microbial environment. Curr Eye Res. 44(7):685–694.
  • Perez VL, Stern ME, Pflugfelder SC. 2020. Inflammatory basis for dry eye disease flares. Exp Eye Res. 201:108294.
  • Periman LM, Perez VL, Saban DR, Lin MC, Neri P. 2020. The immunological basis of dry eye disease and current topical treatment options. J Ocul Pharmacol Ther. 36(3):137–146.
  • Pickering H, Palmer CD, Houghton J, Makalo P, Joof H, Derrick T, Goncalves A, Mabey DCW, Bailey RL, Burton MJ, et al. 2019. Conjunctival microbiome-host responses are associated with impaired epithelial cell health in both early and late stages of trachoma. Front Cell Infect Microbiol. 9:297.
  • Priyadarsini S, Sarker-Nag A, Allegood J, Chalfant C, Karamichos D. 2015. Description of the sphingolipid content and subspecies in the diabetic cornea. Curr Eye Res. 40(12):1204–1210.
  • Qi Y, Wan Y, Li T, Zhang M, Song Y, Hu Y, Sun Y, Li L. 2021. Comparison of the ocular microbiomes of dry eye patients with and without autoimmune disease. Front Cell Infect Microbiol. 11:716867.
  • Ridlon JM, Ikegawa S, Alves JMP, Zhou B, Kobayashi A, Iida T, Mitamura K, Tanabe G, Serrano M, De Guzman A, et al. 2013. Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens. J Lipid Res. 54(9):2437–2449.
  • Riegel P, Ruimy R, de Briel D, Prévost G, Jehl F, Christen R, Monteil H. 1995. Genomic diversity and phylogenetic relationships among lipid-requiring diphtheroids from humans and characterization of Corynebacterium macginleyi sp. nov. Int J Syst Bacteriol. 45(1):128–133.
  • Roda M, Corazza I, Bacchi Reggiani ML, Pellegrini M, Taroni L, Giannaccare G, Versura P. 2020. Dry eye disease and tear cytokine levels - a meta-analysis. Int J Mol Sci. 21(9):3111.
  • Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, Komiya K, Kawaguchi M, Shimizu T, Ogihara T, et al. 2014. Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care. 37(8):2343–2350.
  • Seifart U, Strempel I. 1994. The dry eye and diabetes mellitus. Ophthalmologe. 91(2):235–239.
  • Shi L, Yu X, Yang H, Wu X. 2013. Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways. PLoS One. 8(6):e66781.
  • Shih KC, Lam KS, Tong L. 2017. A systematic review on the impact of diabetes mellitus on the ocular surface. Nutr Diabetes. 7(3):e251.
  • Shimizu E, Ogawa Y, Saijo Y, Yamane M, Uchino M, Kamoi M, Fukui M, Yang F, He J, Mukai S, et al. 2019. Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease. Ocul Surf. 17(2):265–271.
  • Shoari A, Kanavi MR, Rasaee MJ. 2021. Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study. Exp Eye Res. 205:108523.
  • St Leger AJ, Desai JV, Drummond RA, Kugadas A, Almaghrabi F, Silver P, Raychaudhuri K, Gadjeva M, Iwakura Y, Lionakis MS, et al. 2017. An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal γδ T cells. Immunity. 47(1):148–158.
  • Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na K-S, Schaumberg D, Uchino M, Vehof J, et al. 2017. TFOS DEWS II Epidemiology Report. Ocul Surf. 15(3):334–365.
  • Strandwitz P. 2018. Neurotransmitter modulation by the gut microbiota. Brain Res. 1693(B):128–133.
  • Subbarayal B, Chauhan SK, Di Zazzo A, Dana R. 2016. IL-17 augments B cell activation in ocular surface autoimmunity. J Immunol. 197(9):3464–3470.
  • Tam K, Torres VJ. 2019. Staphylococcus aureus secreted toxins and extracellular enzymes. Microbiol Spectr. 7(2):10–11.
  • Ueta M, Kinoshita S. 2010. Innate immunity of the ocular surface. Brain Res Bull. 81(2–3):219–228.
  • Ueta M, Nochi T, Jang M-H, Park EJ, Igarashi O, Hino A, Kawasaki S, Shikina T, Hiroi T, Kinoshita S, et al. 2004. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol. 173(5):3337–3347.
  • Wang LX, Deng YP. 2021. Androgen and meibomian gland dysfunction: from basic molecular biology to clinical applications. Int J Ophthalmol. 14(6):915–922.
  • Wang S, Jia Y, Li T, Wang A, Gao L, Yang C, Zou H. 2019. Dry eye disease is more prevalent in children with diabetes than in those without diabetes. Curr Eye Res. 44(12):1299–1305.
  • Wang Y, Pei G, Cai YC, Zhao ZQ, Wang JB, Jiang CL, Zheng ZC, Liu XY. 1996. Human interleukin-2 could bind to opioid receptor and induce corresponding signal transduction. Neuroreport. 8(1):11–14.
  • Wei Y, Asbell PA. 2014. The core mechanism of dry eye disease is inflammation. Eye Contact Lens. 40(4):248–256.
  • Wen X, Miao L, Deng Y, Bible PW, Hu X, Zou Y, Liu Y, Guo S, Liang J, Chen T, et al. 2017. The influence of age and sex on ocular surface microbiota in healthy adults. Invest Ophthalmol Vis Sci. 58(14):6030–6037.
  • Willcox MD. 2013. Characterization of the normal microbiota of the ocular surface. Exp Eye Res. 117:99–105.
  • Willis KA, Postnikoff CK, Freeman A, Rezonzew G, Nichols K, Gaggar A, Lal CV. 2020. The closed eye harbours a unique microbiome in dry eye disease. Sci Rep. 10(1):12035.
  • Xiao Y, de Paiva CS, Yu Z, de Souza RG, Li D-Q, Pflugfelder SC. 2018. Goblet cell-produced retinoic acid suppresses CD86 expression and IL-12 production in bone marrow-derived cells. Int Immunol. 30(10):457–470.
  • Yarwood JM, Schlievert PM. 2003. Quorum sensing in Staphylococcus infections. J Clin Invest. 112(11):1620–1625.
  • Yerramothu P, Vijay AK, Willcox MDP. 2018. Inflammasomes, the eye and anti-inflammasome therapy. Eye. 32(3):491–505.
  • Zhang X, Jeyalatha MV, Qu Y, He X, Ou S, Bu J, Jia C, Wang J, Wu H, Liu Z, et al. 2017. Dry eye management: targeting the ocular surface microenvironment. Int J Mol Sci. 18(7):1398.
  • Zhang Z, Zou X, Xue W, Zhang P, Wang S, Zou H. 2021. Ocular surface microbiota in diabetic patients with dry eye disease. Invest Ophthalmol Vis Sci. 62(12):13.
  • Zhao F, Zhang D, Ge C, Zhang L, Reinach PS, Tian X, Tao C, Zhao Z, Zhao C, Fu W, et al. 2020. Metagenomic profiling of ocular surface microbiome changes in meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 61(8):22.
  • Zhou Y, Holland MJ, Makalo P, Joof H, Roberts CH, Mabey DC, Bailey RL, Burton MJ, Weinstock GM, Burr SE, et al. 2014. The conjunctival microbiome in health and trachomatous disease: a case control study. Genome Med. 6(11):99.
  • Zhu X, Wei L, Rong X, Zhang Y, Zhang Q, Wen X, He W, Zhang K, Chen F, Wei L, et al. 2021. Conjunctival microbiota in patients with type 2 diabetes mellitus and influences of perioperative use of topical levofloxacin in ocular surgery. Front Med. 8:605639.
  • Zoukhri D, Hodges RR, Byon D, Kublin CL. 2002. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci. 43(5):1429–1436.